🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the trial is to evaluate the efficacy of fluticaso...
Status
Recruiting
Location
Teva Investigational Site 12087
Start Date
2024-12-12
Trial ID
NCT06664619
The purpose of the study is to determine the appropriate dose of fluticason...
Status
Completed
Location
Research Site
Start Date
2006-11
Trial ID
NCT00403286
The purpose of this study is to compare the early onset of effect of Symbic...
Status
Completed
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT00646620
Treatments Being Tested
The purpose of this study is to determine whether a commonly prescribed ora...
Status
Completed
Location
Multiple Locations
Start Date
2014-09
Trial ID
NCT02338362
Treatments Being Tested
This study will evaluate the effects of inhaled fluticasone on cell counts ...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00869596
The purpose of this pilot study is to compare the effects (effectiveness an...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-03
Trial ID
NCT00730756
Treatments Being Tested
Chronic obstructive pulmonary disease (COPD) is characterized by pulmonary ...
Status
Completed
Location
Hospital Son Llatzer
Start Date
2004-02
Trial ID
NCT02209974
Treatments Being Tested
The purpose of this study is to find a more effective treatment for allergi...
Status
Terminated
Location
Emory Hospital Midtown-Otolaryngology
Start Date
2023-10-26
Trial ID
NCT05545072
Treatments Being Tested
We hypothesize that once daily use of oxymetazoline will not cause signific...
Status
Completed
Location
University of Chicago
Start Date
2007-06
Trial ID
NCT00584987
Treatments Being Tested
There are new, very sensitive methods for detecting bacteria. These methods...
Status
Completed
Location
University of California, San Francisco, Adult
Start Date
2012-10
Trial ID
NCT01537133
Treatments Being Tested